About this source
- Kind
- Research
- Design
- Human clinical trial, RCT
- Population
- Human, HIV-infected adults with abdominal fat accumulation
- Primary or secondary
- primary
- Peer review
- peer reviewed
- Retraction status
- None known
- Date checked
- 14 August 2026
Limitations
Population-specific to HIV-associated lipodystrophy; do not generalise to a non-HIV population.
Cited in
HIV visceral fat trial
Tesamorelin · Research finding
Strong
Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.